BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8080884)

  • 1. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.
    van Genderen PJ; Michiels JJ; van der Poel-van de Luytgaarde SC; van Vliet HH
    Ann Hematol; 1994 Aug; 69(2):81-4. PubMed ID: 8080884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome.
    Magyari F; Kracskó B; Bedekovics J; Bereczky Z; Illés Á; Schlammadinger Á
    Hematology; 2021 Dec; 26(1):301-304. PubMed ID: 33663351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
    Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
    Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):147-51. PubMed ID: 10725999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).
    Rupa-Matysek J; Lewandowski K; Lewandowska M; Wojtasińska E; Wojtaszewska ML; Walczak M; Bykowska K; Komarnicki M
    Int J Hematol; 2015 Apr; 101(4):405-10. PubMed ID: 25432436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful management of intraperitoneal bleeding with platelet apheresis and von Willebrand factor supplementation in a patient with essential thrombocythemia and acquired von Willebrand syndrome].
    Ueki T; Takeshige K; Sumi M; Ueno M; Ichikawa N; Kobayashi H
    Rinsho Ketsueki; 2017; 58(8):922-926. PubMed ID: 28883275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children.
    Knöfler R; Lange BS; Paul F; Tiebel O; Suttorp M
    Br J Haematol; 2020 Mar; 188(5):701-706. PubMed ID: 31617211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link?
    van Genderen PJ; Leenknegt H; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):385-9. PubMed ID: 9263356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.
    Kogan L; Price R; Kotchetkov R
    Front Oncol; 2024; 14():1326209. PubMed ID: 38361779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
    Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
    Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma.
    van Genderen PJ; van Vliet HH; Prins FJ; van de Moesdijk D; van Strik R; Zijlstra FJ; Budde U; Michiels JJ
    Ann Hematol; 1997; 75(5-6):215-20. PubMed ID: 9433378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand disease in myeloproliferative disorders.
    van Genderen PJ; Leenknegt H; Michiels JJ; Budde U
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():79-82. PubMed ID: 8951776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count.
    van Genderen PJ; Budde U; Michiels JJ; van Strik R; van Vliet HH
    Br J Haematol; 1996 Jun; 93(4):962-5. PubMed ID: 8703834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea.
    Verner E; Forsyth C; Grigg A
    Leuk Lymphoma; 2014 May; 55(5):1139-43. PubMed ID: 23879199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.
    Schneider C; Stutz-Grunder E; Lüer S; Keller P; Kremer Hovinga JA; Ammann RA; Karow A
    Hamostaseologie; 2019 Nov; 39(4):404-408. PubMed ID: 30895567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome.
    Casonato A; Pontara E; Doria A; Bertomoro A; Cattini MG; Gambari PF; Girolami A
    Br J Haematol; 2002 Mar; 116(4):899-904. PubMed ID: 11886398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.